Company Search:
Advanced Search
Sponsored Links
DuPont de Nemours Inc Company Snapshot
DuPont de Nemours Inc operates within the Medicinals and botanicals sector. In addition to historical fundamental analyses, the complete report available to purchase compares DuPont de Nemours Inc with three other pharmaceutical manufacturers in North America: Gilead Sciences, Inc. (2019 sales of $22.45 billion of which 100% was discovery, development and commercializa), Eli Lilly and Company ($22.32 billion of which 100% was Human Pharmaceuticals products), and Amgen Inc. ($23.36 billion of which 22% was Enbrel).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
DuPont de Nemours Inc
  Stock Performance Chart for DuPont de Nemours Inc
  Stock Data: Recent Stock Performance:
  Current Price (11/20/2020): 62.55
(Figures in U.S. Dollars)
1 Week 1.5%   13 Weeks 4.6%  
4 Weeks 13.4%   52 Weeks -5.0%  
DuPont de Nemours Inc Key Data:
  Ticker: DD Country: United States
  Exchanges: NYSE Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Medicinals & Botanicals
  2019 Sales 21,512,000,000
(Year Ending Jan 2020).
Employees: 35,000
  Currency: U.S. Dollars Market Cap: 45,902,029,207
  Fiscal Yr Ends: December Shares Outstanding: 733,845,391
  Share Type: Common Closely Held Shares: 752,055
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.